|
Dec 4
|
Exelixis and Arcus Biosciences Announce Clinical Trial Collaboration to Evaluate Zanzalintinib in Combination with AB521 in Patients with Advanced Renal Cell Carcinoma
|
|
Oct 17
|
Arcus Biosciences to Present Data from Ongoing EDGE-Gastric Study at ASCO Plenary and to Report Third-Quarter Financial Results on November 7
|
|
Aug 7
|
Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Misses Revenue Estimates
|
|
Aug 7
|
Arcus Biosciences Reports Second-Quarter 2023 Financial Results and Provides a Pipeline Update
|
|
Aug 3
|
Prothena (PRTA) Reports Q2 Loss, Lags Revenue Estimates
|
|
Apr 25
|
Arcus Biosciences Announces New Employment Inducement Grants
|